TABLE 1.
Characteristics, treatments, and BCRL risk factors of patients enrolled, by trial arm
| SAD | AD | |||
|---|---|---|---|---|
| 65 patients | 65 patients | |||
| N | % | N | % | |
| Age, median (IQR), y | 52 (46‐60) | 51 (45‐63) | ||
| BMI, kg/m2: median (IQR) | 21.8 (19.9‐26.3) | 23.0 (20.3‐25.4) | ||
| Dominant side affected | 28 | 43.1 | 31 | 47.7 |
| Surgical treatment | ||||
| Wide excision | 30 | 46.2 | 33 | 50.8 |
| Mastectomy | 34 | 52.3 | 32 | 49.2 |
| Axillary surgery alone | 1 | 1.5 | 0 | ‐ |
| Axillary assessment by prior SLNB | 20 | 30.8 | 22 | 33.8 |
| No. of excised nodes: median (IQR) | 17.0 (14.0‐23.0) | 19.0 (16.0‐24.0) | ||
| No. of involved nodes: median (IQR) | 2.0 (1.0‐5.0) | 2.0 (1.0‐4.0) | ||
| Systemic treatment | ||||
| Neoadjuvant | 23 | 35.4 | 13 | 20.0 |
| Adjuvant | 42 | 64.6 | 52 | 80.0 |
| Radiation treatment | ||||
| Breast | 31 | 47.7 | 33 | 50.8 |
| Chest wall | 22 | 33.8 | 22 | 33.8 |
| Supra‐infraclavicular | 25 | 38.5 | 24 | 36.9 |
Abbreviations: AD, axial dissection; BCRL, breast cancer–related lymphedema; BMI, body mass index; IQR, interquartile range; SAD, selective axillary dissection; SLNB, sentinel lymph‐node biopsy.